We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
+4.67%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$218M
AUM Growth
+$15M
Cap. Flow
+$5.2M
Cap. Flow %
2.38%
Top 10 Hldgs %
32.57%
Holding
102
New
8
Increased
36
Reduced
32
Closed
3

Top Buys

Rank Stock Value
1
XYL icon
Xylem
XYL
+$679K
2
QCOM icon
Qualcomm
QCOM
+$663K
3
XLNX
Xilinx Inc
XLNX
+$599K
4
ABT icon
Abbott
ABT
+$595K
5
JCI icon
Johnson Controls International
JCI
+$494K

Top Sells

Rank Stock Value
1
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$1.6M
2
LH icon
Labcorp
LH
+$928K
3
PEP icon
PepsiCo
PEP
+$503K
4
XOM icon
ExxonMobil
XOM
+$399K
5
EPZM
Epizyme, Inc
EPZM
+$235K

Sector Composition

Rank Sector Weight
1 Healthcare 21.67%
2 Industrials 18.53%
3 Technology 18.53%
4 Energy 15.05%
5 Consumer Staples 6.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KO icon
51
Coca-Cola
KO
$353B
$1.1M 0.5%
26,015
– –
COP icon
52
ConocoPhillips
COP
$141B
$1.09M 0.5%
12,709
-540
-4% -$42.1K
TGT icon
53
Target
TGT
$63.4B
$1.08M 0.49%
18,565
+7,495
+68% +$441K
XYL icon
54
Xylem
XYL
$28.7B
$710K 0.33%
+18,175
New +$679K
MCD icon
55
McDonald's
MCD
$190B
$626K 0.29%
6,220
-120
-2% -$12.1K
TT icon
56
Trane Technologies
TT
$103B
$599K 0.27%
9,586
– –
CI icon
57
Cigna
CI
$75.1B
$596K 0.27%
6,480
– –
ILMN icon
58
Illumina
ILMN
$27.9B
$544K 0.25%
+3,132
New +$467K
PSX icon
59
Phillips 66
PSX
$83.7B
$511K 0.23%
6,348
-59
-0.9% -$4.86K
PFE icon
60
Pfizer
PFE
$141B
$490K 0.22%
17,423
– –
EPZM
61
DELISTED
Epizyme, Inc
EPZM
$467K 0.21%
15,000
-10,000
-40% -$235K
IONS icon
62
Ionis Pharmaceuticals
IONS
$8.75B
$464K 0.21%
+13,453
New +$424K
NEE icon
63
NextEra Energy
NEE
$184B
$455K 0.21%
17,760
– –
KMB icon
64
Kimberly-Clark
KMB
$36B
$448K 0.21%
4,203
– –
BAX icon
65
Baxter International
BAX
$11.4B
$394K 0.18%
10,011
– –
STT icon
66
State Street
STT
$50.2B
$393K 0.18%
5,854
-700
-11% -$46K
SJT
67
San Juan Basin Royalty Trust
SJT
$126M
$349K 0.16%
18,050
+300
+2% +$5.64K
CSX icon
68
CSX Corp
CSX
$93.1B
$339K 0.16%
33,000
-1,800
-5% -$17.5K
APC
69
DELISTED
Anadarko Petroleum
APC
$333K 0.15%
3,040
– –
CAT icon
70
Caterpillar
CAT
$398B
$329K 0.15%
3,024
– –
GIS icon
71
General Mills
GIS
$20.1B
$310K 0.14%
5,900
-200
-3% -$10.7K
ALNY icon
72
Alnylam Pharmaceuticals
ALNY
$36.4B
$309K 0.14%
4,878
+120
+3% +$7.13K
NGG icon
73
National Grid
NGG
$82B
$288K 0.13%
4,017
– –
LLY icon
74
Eli Lilly
LLY
$1.02T
$286K 0.13%
4,600
-100
-2% -$5.97K
T icon
75
AT&T
T
$153B
$225K 0.1%
8,441
-1,191
-12% -$31.9K
1 2
3
4

Similar funds

MAM
Monaco Asset Management Monaco $542M AUM 54.4% 1-Year Est. Return
GPWA
Great Point Wealth Advisors Boston, Massachusetts $542M AUM
WCA
Westover Capital Advisors Wilmington, Delaware $543M AUM 36.85% 1-Year Est. Return
ISB
Iowa State Bank Urbandale, Iowa $543M AUM 21.44% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return
FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
HCM
Hutchinson Capital Management San Rafael, California $544M AUM 9.54% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $544M AUM 18.82% 1-Year Est. Return

Brian C. Broderick's Q2 2014 Portfolio in Review

As of Q2 2014, Brian C. Broderick held 102 positions worth $218M, up 7.4% from $203M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Brian C. Broderick's Q2 2014 filing shows 8 new, 36 increased, 32 reduced and 3 closed positions. Its largest new stake was Xylem: 18,175 shares worth $710K. The largest sale was COVIDIEN PLC COM SHS NEW (IRELAND), an estimated $1.6M.

By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 22% a quarter earlier, followed by Industrials and Technology.

  • Brian C. Broderick's largest Q2 2014 buy was Xylem: 18,175 shares worth $710K.
  • Brian C. Broderick added most to Qualcomm in Q2 2014, an estimated $663K increase.
  • Brian C. Broderick's biggest Q2 2014 reduction was COVIDIEN PLC COM SHS NEW (IRELAND), cutting an estimated $1.6M.
  • Brian C. Broderick fully exited Labcorp in Q2 2014, selling an estimated $928K.
  • Brian C. Broderick's ten largest holdings make up 33% of its $218M portfolio in Q2 2014.
  • Brian C. Broderick opened 8 new positions and closed 3 in Q2 2014.
  • Brian C. Broderick's portfolio value rose 7.4% quarter-over-quarter to $218M.

Based on Brian C. Broderick's 13F filing for Q2 2014, filed 23 Jul 2014.